Literature DB >> 21863340

TSH receptor extracellular region mutations in thyroid functioning nodules: further evidence for the functional role of this region in the receptor activation.

D Russo, G Costante, R Bruno, M Sponziello, G Tamburrano, M Dima, R Sacco, L Giacomelli, C Durante, S Filetti.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21863340     DOI： 10.1007/s12020-011-9525-7

Source DB:  PubMed          Journal:  Endocrine        ISSN： 1355-008X            Impact factor:   3.633


× No keyword cloud information.
  12 in total

Review 1.  Genetic hyperthyroidism: hyperthyroidism due to activating TSHR mutations.

Authors:  A Hébrant; W C G van Staveren; C Maenhaut; J E Dumont; J Leclère
Journal:  Eur J Endocrinol       Date:  2010-10-06       Impact factor: 6.664

2.  A novel mutation in the thyrotropin (TSH) receptor gene causing loss of TSH binding but constitutive receptor activation in a family with resistance to TSH.

Authors:  D Russo; C Betterle; F Arturi; E Chiefari; M E Girelli; S Filetti
Journal:  J Clin Endocrinol Metab       Date:  2000-11       Impact factor: 5.958

3.  A Val 677 activating mutation of the thyrotropin receptor in a Hürthle cell thyroid carcinoma associated with thyrotoxicosis.

Authors:  D Russo; M G Wong; G Costante; E Chiefari; P A Treseler; F Arturi; S Filetti; O H Clark
Journal:  Thyroid       Date:  1999-01       Impact factor: 6.568

Review 4.  Molecular insights into TSH receptor abnormality and thyroid disease.

Authors:  D Russo; F Arturi; E Chiefari; S Filetti
Journal:  J Endocrinol Invest       Date:  1997-01       Impact factor: 4.256

5.  Thyrotropin (TSH) receptor residue E251 in the extracellular leucine-rich repeat domain is critical for linking TSH binding to receptor activation.

Authors:  Chun-Rong Chen; Sandra M McLachlan; Basil Rapoport
Journal:  Endocrinology       Date:  2010-02-24       Impact factor: 4.736

6.  Evidence that the thyroid-stimulating hormone (TSH) receptor transmembrane domain influences kinetics of TSH binding to the receptor ectodomain.

Authors:  Chun-Rong Chen; Sandra M McLachlan; Basil Rapoport
Journal:  J Biol Chem       Date:  2010-12-28       Impact factor: 5.157

7.  Deletion of thyrotropin receptor residue Asp403 in a hyperfunctioning thyroid nodule provides insight into the role of the ectodomain in ligand-induced receptor activation.

Authors:  E Nishihara; C-R Chen; Y Mizutori-Sasai; M Ito; S Kubota; N Amino; A Miyauchi; B Rapoport
Journal:  J Endocrinol Invest       Date:  2011-05-19       Impact factor: 4.256

8.  A Phe 486 thyrotropin receptor mutation in an autonomously functioning follicular carcinoma that was causing hyperthyroidism.

Authors:  P Camacho; D Gordon; E Chiefari; S Yong; S DeJong; S Pitale; D Russo; S Filetti
Journal:  Thyroid       Date:  2000-11       Impact factor: 6.568

Review 9.  Thyrotropin and homologous glycoprotein hormone receptors: structural and functional aspects of extracellular signaling mechanisms.

Authors:  Gunnar Kleinau; Gerd Krause
Journal:  Endocr Rev       Date:  2009-01-27       Impact factor: 19.871

10.  Contacts between extracellular loop two and transmembrane helix six determine basal activity of the thyroid-stimulating hormone receptor.

Authors:  Gunnar Kleinau; Maren Claus; Holger Jaeschke; Sandra Mueller; Susanne Neumann; Ralf Paschke; Gerd Krause
Journal:  J Biol Chem       Date:  2006-11-01       Impact factor: 5.157
View more
  2 in total

1.  Increased expression of pro-angiogenic factors and vascularization in thyroid hyperfunctioning adenomas with and without TSH receptor activating mutations.

Authors:  Marilena Celano; Marialuisa Sponziello; Giovanni Tallini; Valentina Maggisano; Rocco Bruno; Mariavittoria Dima; Enrico Di Oto; Adriano Redler; Cosimo Durante; Rosario Sacco; Sebastiano Filetti; Diego Russo
Journal:  Endocrine       Date:  2012-07-20       Impact factor: 3.633

Review 2.  Novel insights on thyroid-stimulating hormone receptor signal transduction.

Authors:  Gunnar Kleinau; Susanne Neumann; Annette Grüters; Heiko Krude; Heike Biebermann
Journal:  Endocr Rev       Date:  2013-05-03       Impact factor: 19.871
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.